Purpose: The purpose of this study is to report a case series of two patients with chemotherapy induced neutropenia who prescribed herbal medicine during their period of hospitalization.
Methods: Samultanggagambang was prescribed three times a day to two patients with chemotherapy induced neutropenia. Complete blood cell count is measured before and after administration of samultanggagambang.
Results: ANC (Absolute Neutrophil Count) was gradually increased during the administration of samultanggagambang. Case 1 was a 51-year-old female patient. The initial diagnosis was made in December, 2013 with right breast cancer, IIB (pT 2N1M0). Neoadjuvant chemotherapy was administered from December, 2013 to February, 2014. Partial mastectomy was performed on March, 2014. Adjuvant chemotherapy was administered from April, 2014 every three weeks with Docetaxel. The patient was hospitalized on 19, May after second chemotherapy on 12, May. The patient was isolated in single room on 20, May with ANC 340. Filgrastim was administered once and Samultanggagambang was prescribed three times a day. ANC was recovered as 2083 on 26, May. Case 2 was a 46-year-old female patient. The initial diagnosis was made in April, 2014 with advanced gastric cancer, IIIB (pT3N2M0). A total gastrectomy was performed on two weeks later. Adjuvant chemotherapy was administered from May, 2014 every three weeks with Xeloda and Oxaliplatin. The patient was hospitalized on 19, May after first chemotherapy on 15, May. The patient was isolated in multi-bed room on 20, May with ANC 974. Samultanggagambang was prescribed three times a day. Even though, Capecitabine 2,300 mg was administered until 28, May ANC was recovered as 3,419 on 2, June.
Conclusion: Samultanggagambang has shown benefit in improving chemotherapy induced neutropenia. It is expected to be a promising treatment for improving chemotherapy induced neutropenia and more clinical research will be required for evidence based medicine.
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